Stocks
News
ETFs
Economy
Currencies
Press Releases
Articles from Causeway Therapeutics Ltd
Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed Patients
By
Causeway Therapeutics Ltd
· Via
GlobeNewswire
· March 19, 2026
Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed Patients
By
Causeway Therapeutics Ltd
· Via
GlobeNewswire
· October 28, 2025
